Related Experiment Video
Updated: Jul 31, 2026

16:57
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
26.4K
Molecular determinants for brain targeting by peptides: a meta-analysis approach with experimental validation
Marco Cavaco1,2, Patrícia Fraga1, Javier Valle2
1Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028, Lisbon, Portugal.
Fluids and Barriers of the CNS
|May 27, 2024
Summary
Researchers identified key properties of blood-brain barrier peptide-shuttles (BBBpS), distinguishing them from cell-penetrating peptides (CPPs). This work aids in designing peptides for effective brain targeting and identifies new BBBpS candidates.
Area of Science:
- Pharmacology and Neuroscience
- Biochemistry and Molecular Biology
- Drug Delivery Systems
Background:
- Blood-brain barrier peptide-shuttles (BBBpS) are crucial for brain drug delivery but are poorly understood.
- Current BBBpS development often incorrectly assumes cell-penetrating peptides (CPPs) will function as BBBpS.
- The precise relationship between CPPs and BBBpS requires thorough experimental investigation.
Purpose of the Study:
- To characterize the physicochemical properties of effective BBBpS.
- To establish a methodology for identifying and designing novel peptide-based brain-targeting agents.
- To discover new BBBpS from existing CPP libraries.
Main Methods:
- Identified and quantified key physicochemical properties of known BBBpS.
- Searched for cell-penetrating peptides (CPPs) exhibiting these identified BBBpS properties.
- Utilized ordinary least squares analysis to select top-scoring CPP candidates for in vitro and in vivo testing.
Main Results:
- Defined specific physicochemical features of BBBpS: small size, few aromatic residues, hydrophobicity, and slight cationic nature.
- Identified the critical molecular determinants governing peptide brain targeting.
- Validated four novel BBBpS candidates from the tested CPP library.
Conclusions:
- Established a data-driven approach to differentiate and design BBBpS.
- Provided a valuable methodology for peptide-based brain drug delivery system development.
- Successfully identified new peptide shuttles capable of crossing the blood-brain barrier.
Keywords:
Blood–brain barrier (BBB)Blood–brain barrier peptide shuttles (BBBpS)Brain deliveryCell-penetrating peptides (CPPs)Neurological disorders
